MedDataX Logo

Database of Pelvic Inflammatory Disease

NCT ID: NCT02567812

Last Updated: 2019-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-31

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this prospective study is to collect data on in-patients with pelvic inflammatory disease(PID) at Kangbuk Samsung Hospital.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study for Rapid Diagnosis of Postoperative Abdominal Infection

NCT05187871

Postoperative Infection Abdominal Surgery Intra-abdominal Infection +1 more
UNKNOWN

Baseline Study of Vaginal Microbiota in Healthy Chinses Female Population

NCT04887636

Vagina Disease Vaginal Community State Type
COMPLETED

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases

NCT04698148

Clostridium Difficile Infection Multi Drug Resistant Organisms Chronic Inflammatory Bowel Disease +2 more
COMPLETED

One Sequencing Find All for Helicobacter Pylori Infection

NCT03837990

Helicobacter Pylori Infection Resistant Infection
UNKNOWN

A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

NCT00952796

Intra-abdominal Infection
COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this prospective study is to collect data on in-patients with pelvic inflammatory disease(PID) at Kangbuk Samsung Hospital. If patients agree to participate in this clinical trial, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database. The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care. Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Pelvic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

In-patient with PID

In-patient with PID who diagnosed at Kangbuk Samsung Hospital

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All in-patient with PID who diagnosed at Kangbuk Samsung Hospital

Exclusion Criteria

* Secondary PID caused by other surgical problem or disease
* An inability to fill-up the informed consent
Minimum Eligible Age

19 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kangbuk Samsung Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Taejong Song

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Taejong Song, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Kangbuk Samsung Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Taejong Song, MD PhD

Role: CONTACT

[email protected]
+82-10-4035-8405

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Taejong Song, MD PhD

Role: primary

[email protected]
82-2-2001-2582

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-04-009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Integrated Genetic and Functional Analysis of the Female Microbiome in a Flemish Cohort
NCT04319536 UNKNOWN
A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)
NCT04035785 UNKNOWN PHASE4
Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract
NCT00511212 WITHDRAWN NA
Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
NCT00783419 COMPLETED
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
NCT01138566 UNKNOWN
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases
NCT04689074 COMPLETED
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
NCT07093593 NOT_YET_RECRUITING NA
The Urinary Microbiome and Its Relationship to the Urinary and Serum Metabolome in Healthy Peri- and Postmenopausal Women
NCT06573827 NOT_YET_RECRUITING
Clinical Metagenomic of Post-traumatic Infections
NCT05770856 COMPLETED
Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
NCT02031588 TERMINATED
Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study
NCT05521139 COMPLETED
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
NCT00573521 COMPLETED
Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP
NCT02098486 COMPLETED PHASE2
Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections
NCT01726023 COMPLETED PHASE3
Uterine Microbiome in Women with Repeated Implantation Failure and Normal Fertile Women
NCT03405883 COMPLETED
Study Evaluating the Etiology of Intra-Abdominal Infections
NCT00244088 COMPLETED
Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients
NCT00235664 COMPLETED
An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)
NCT00092170 COMPLETED PHASE2
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
NCT06910878 RECRUITING
A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)
NCT00157898 COMPLETED PHASE4
Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research
NCT06466707 RECRUITING NA
IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres
NCT02689193 COMPLETED
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 COMPLETED
Study of the Intestinal Microbiota
NCT07058961 RECRUITING
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 UNKNOWN